Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Peter Winter, Anette Breindl, Mari Serebrov, Marie Powers, Randy Osborne, Michael Fitzhugh

35860 followers  •  9906 follow  •    •

Looming tax shake-up to force Ireland onto level playing pitch…

Phathom goes deeper into GERD; sea change ahead for PPIs?…

Stonewise raises $100M in B and B+ rounds to advance AI-enabled drug discovery

Recursion’s IPO set to be 2021’s second highest…

Affimed aims to Rock NK space, put tumors on ICE…

Rising approvals and regulatory news in March; NMEs for ADHD and MS…


British Biosimilars Association aims to propel awareness, understanding of #biosimilars  among U.K. clinicians

. Special 301 Trade Report takes aim at unfair practices in and sect #biopharmars ; #meddevice2  countries named to Priority Watch List and some highly industrialized trade partners called out

Two girls with leukemia cured with @cellectis ' CAR-T cells

Inovio's COVID-19 vaccine appears active against variants

The U.S. @DeptofDefense  has awarded @NovavaxInc  $60M to fund manufacture of 10 million doses of its COVID-19 vaccine candidate NVX‑CoV2373 for use in phase II/III trials, or under an Emergency Use Authorization, if approved @US_FDAby  . $N #COVID19AX 

Following a single dose of @regeneron 's antibody cocktail on Friday, President Trump's physician has elected to start him on a course of @GileadSciences ' Veklury (remdesivir), a move suggested as one possible option earlier in the day by @ScottGottliebMD .

Trillium follows positive data and $25M equity investment with $130M offering

Novavax coronavirus vaccine, Bellerophon COVID-19 therapy near phase I

@genentech  plans to move its IL-6 inhibitor, Actemra (tocilizumab), into a global phase III trial in patients with severe pneumonia associated with COVID-19 infection

COVID-19 drug development continues to surge